Official Title:  A Multicenter, Randomized, Open-label   Parallel  Group  Pilot Study to 
Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG )
Plus Standard Medical Treatment  (SMT) Versus SMT Alone in Subjects With  
COVID-19 Requiring Admission to the Intensive Care Unit
Study ID: [REMOVED]
Document  Date : Protocol Version 4.0: 19 July 2021